• Pharma reps are a dieing breed, fossils abound. [MM&M]

• The Washington Post does its take on biotechs: all sellers, no buyers. [The Washington Post]

• Genentech and Abbott CEOs are the best! [CNBC]

• What’s up with this post? What’s the point? Is Bloomberg hyping up a CTIC pixantrone deal? [Bloomberg]

• A Genentech shareholder has taken their voice to HBO.com? [HBO]

• Less than a month after being accused by the Justice Department for improperly marketing its drug Lexapro to teens, Forest Laboratories receives pediatrics approval for the drug. [Modern Medicine]

• Lilly gets drug approved for treatment-resistant depression. [Forbes]

• Neuromed’s hydromorphone works in Phase 3 trial. [PR Newswire]

• MDRNA and Novartis in licensing deal, MDRNA gets $7.5M upfront. [Puget Sound Business Journal]

And that’s that…

Image from IguanaBio

Related Posts